Markets › United States › NAS › KRYS

Krystal Biotech Inc

NAS:KRYSHealthcareCBOEFTSE:MRUTNASDAQ:NBI

$320.25+1.16%At closeAt close · Tue 20 Oct · ≈ AED 1,176.12 · Market cap $9.48B · Next earnings Mon 2 Nov

USD billions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	YoY
Cash & cash equivalents	0.3	0.3	0.2	0.4	0.3	0.5	+43.9%
Cash & short-term investments	0.3	0.4	0.4	0.5	0.6	0.8	+38.5%
Receivables	0.0	0.0	0.0	0.0	0.1	0.1	+21.7%
Inventory	0.0	0.0	0.0	0.0	0.0	0.0	+52.7%
Total current assets	0.3	0.4	0.4	0.6	0.7	1.0	+38.1%
Property, plant & equipment	0.0	0.1	0.2	0.2	0.2	0.2	−2.1%
Goodwill & intangibles	0.0	0.0	0.0	0.0	0.0	0.0	—
Long-term investments	0.0	0.1	0.0	0.1	0.2	0.1	−15.8%
Total assets	0.3	0.6	0.6	0.8	1.1	1.3	+26.3%
Payables	0.0	0.0	0.0	0.0	0.0	0.0	−35.0%
Short-term debt	0.0	0.0	0.0	0.0	0.0	0.0	—
Total current liabilities	0.0	0.0	0.0	0.0	0.1	0.1	+0.9%
Long-term debt	0.0	0.0	0.0	0.0	0.0	0.0	—
Total debt	0.0	0.0	0.0	0.0	0.0	0.0	+28.6%
Net debt	(0.3)	(0.3)	(0.2)	(0.4)	(0.3)	(0.5)	−44.2%
Deferred revenue	0.0	0.0	0.0	0.0	0.0	0.0	—
Total liabilities	0.0	0.0	0.0	0.0	0.1	0.1	+4.4%
Total equity	0.3	0.6	0.5	0.8	0.9	1.2	+28.9%
Retained earnings	(0.1)	(0.1)	(0.3)	(0.3)	(0.2)	0.0	+113.4%